tetravalent abatacept analog (Korea Prime Pharm)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametetravalent abatacept analog (Korea Prime Pharm)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionT-cell-specific surface glycoprotein CD28 inhibitors
TargetsT-cell-specific surface glycoprotein CD28
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKorea Prime Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea Prime Pharm Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A